Ascentage Pharma Group International (OTCMKTS:ASPHF) Trading Down 3.5% – What’s Next?

Ascentage Pharma Group International (OTCMKTS:ASPHF)’s stock price traded down 3.5% on Friday . The company traded as low as $4.53 and last traded at $4.53. 100 shares were traded during mid-day trading, an increase of 0% from the average session volume of 100 shares. The stock had previously closed at $4.6950.

Ascentage Pharma Group International Stock Down 3.5%

The stock has a 50 day moving average price of $7.36 and a two-hundred day moving average price of $8.11.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.